- Home
- OSRH vs ABP Comparison
OSRH vs ABP Comparison
Compare OSRH & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSRH
- ABP
- Stock Information
- Founded
- OSRH N/A
- ABP 2004
- Country
- OSRH United States
- ABP United States
- Employees
- OSRH N/A
- ABP N/A
- Industry
- OSRH
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- OSRH
- ABP Health Care
- Exchange
- OSRH Nasdaq
- ABP Nasdaq
- Market Cap
- OSRH 13.2M
- ABP 15.2M
- IPO Year
- OSRH N/A
- ABP N/A
- Fundamental
- Price
- OSRH $0.71
- ABP $0.21
- Analyst Decision
- OSRH
- ABP Hold
- Analyst Count
- OSRH 0
- ABP 1
- Target Price
- OSRH N/A
- ABP N/A
- AVG Volume (30 Days)
- OSRH 2.0M
- ABP 4.8M
- Earning Date
- OSRH 11-24-2025
- ABP 11-18-2025
- Dividend Yield
- OSRH N/A
- ABP N/A
- EPS Growth
- OSRH N/A
- ABP N/A
- EPS
- OSRH N/A
- ABP N/A
- Revenue
- OSRH $104,735.00
- ABP $183,000.00
- Revenue This Year
- OSRH N/A
- ABP N/A
- Revenue Next Year
- OSRH N/A
- ABP N/A
- P/E Ratio
- OSRH N/A
- ABP N/A
- Revenue Growth
- OSRH N/A
- ABP 154.17
- 52 Week Low
- OSRH $0.45
- ABP $0.15
- 52 Week High
- OSRH $13.40
- ABP $11.19
- Technical
- Relative Strength Index (RSI)
- OSRH 55.77
- ABP 49.33
- Support Level
- OSRH $0.59
- ABP $0.19
- Resistance Level
- OSRH $0.82
- ABP $0.21
- Average True Range (ATR)
- OSRH 0.11
- ABP 0.02
- MACD
- OSRH 0.02
- ABP 0.00
- Stochastic Oscillator
- OSRH 51.20
- ABP 59.64
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.